Pharma Stability: Insights, Guidelines, and Expertise
Stability Testing for Lyophilized Biologics Comprehensive Guide to Stability Testing for Lyophilized Biologics Lyophilization, or freeze-drying, is a common strategy to improve the shelf life and stability of biopharmaceuticals—particularly those that are sensitive to heat, moisture, or chemical degradation in aqueous form. However, while lyophilized formats offer improved stability, they present unique challenges in stability…
Importance of API Solubility in Freeze-Thaw Resilience Importance of API Solubility in Freeze-Thaw Resilience: A Key Determinant of Stability The solubility of the Active Pharmaceutical Ingredient (API) is a foundational property in drug formulation, directly impacting bioavailability, stability, and manufacturability. In freeze-thaw and thermal cycling studies, API solubility becomes even more critical, as solubility fluctuations…
Read More “Importance of API Solubility in Freeze-Thaw Resilience” »
SOP for Developing a Stability-Indicating Method in Compliance with ICH Q2(R1) Guidelines for Creating Stability-Indicating Methods as per ICH Q2(R1) 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the process for developing and validating a stability-indicating method for drug substances and drug products in accordance with the ICH Q2(R1) guidelines….
Read More “SOP for Developing a Stability-Indicating Method in Compliance with ICH Q2(R1)” »
Stability Testing for Peptide and Protein-Based Drugs: Regulatory and Analytical Best Practices Stability Testing for Peptide and Protein-Based Drugs: Regulatory and Analytical Best Practices Introduction Peptide and protein-based pharmaceuticals—including recombinant proteins, monoclonal antibodies, synthetic peptides, and fusion proteins—are becoming increasingly prevalent due to their high specificity and therapeutic efficacy. However, these biologically derived or synthesized…
Preparing Stability Data Systems for Regulatory Audit Success Audit-Proofing Stability Data Management: A Regulatory Readiness Guide Introduction Regulatory audits are an inevitable and high-stakes component of pharmaceutical quality management. Stability data, which directly support claims related to product shelf life, storage conditions, and quality consistency, are often a focal point during inspections. Agencies like the…
Read More “Preparing Stability Data Systems for Regulatory Audit Success” »
Understanding the Tip: Why scheduling matters in stability programs: Stability studies are long-term endeavors that require careful planning and strict adherence to time points. Missing a sample pull or test window can compromise the integrity of your data and delay critical regulatory filings. A well-organized calendar helps QA and QC teams stay aligned with testing…
Read More “Implement a Calendar System with Automated Reminders for Stability Studies” »
Study Designs for Freeze-Thaw of Topical Formulations Study Designs for Freeze-Thaw of Topical Formulations: Ensuring Stability of Semisolid Dosage Forms Topical formulations such as creams, ointments, gels, and lotions are widely used in pharmaceutical and cosmetic industries. However, their complex emulsion, suspension, or polymeric structures make them particularly vulnerable to temperature stress, including freeze-thaw cycles….
Read More “Study Designs for Freeze-Thaw of Topical Formulations” »
Stability Testing for Cell and Gene Therapy Products Designing and Conducting Stability Studies for Cell and Gene Therapy Products Cell and gene therapy (CGT) products are among the most complex and promising innovations in modern medicine. Unlike traditional biologics, CGTs often contain living cells or genetic material that are highly sensitive to environmental changes, requiring…
Read More “Stability Testing for Cell and Gene Therapy Products” »
Stability Considerations for Gene and Cell Therapy Products Unique Stability Considerations for Gene and Cell Therapy Products Introduction Gene and cell therapies (GCTs), also referred to as advanced therapy medicinal products (ATMPs), are revolutionizing medicine with their potential to address previously untreatable diseases. However, these therapies come with significant challenges, especially in the domain of…
Read More “Stability Considerations for Gene and Cell Therapy Products” »
Mitigation of Precipitate Formation After Thawing Mitigation of Precipitate Formation After Thawing in Freeze-Thaw Stability Testing Precipitate formation following freeze-thaw cycles is a common physical stability issue in pharmaceutical formulations—particularly in protein-based injectables, suspensions, and emulsions. These visible or subvisible particles often indicate irreversible instability, potentially affecting potency, bioavailability, and patient safety. Regulatory agencies treat…
Read More “Mitigation of Precipitate Formation After Thawing” »
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.